Capsaicin (8-Methyl-N-Vanillyl-6-Nonenamide) Is a Potent Inhibitor of Nuclear Transcription Factor-κB Activation by Diverse Agents

Journal of Immunology

Volumn 157, Issue 10, 1996, Pages 4412-4420

  Singh, Sanjaya ^a,b   Natarajan, K ^a   Aggarwal, Bharat B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSAICIN; DITERPENE; DNA BINDING PROTEIN; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NEUROTOXIN; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; PHORBOL 13 ACETATE 12 MYRISTATE; RESINIFERATOXIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; GENETIC TRANSCRIPTION; HELA CELL; HUMAN; IMMUNOLOGY; METABOLISM; MYELOMONOCYTIC LEUKEMIA;

CAPSAICIN; DITERPENES; DNA-BINDING PROTEINS; HELA CELLS; HUMANS; I-KAPPA B PROTEINS; LEUKEMIA, MYELOMONOCYTIC, ACUTE; NEUROTOXINS; NF-KAPPA B; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030588541     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Siebenlist, U., G. Franzo, and K. Brown. 1994. Structure, regulation and function of NF-κB. Annu. Rev. Cell Biol. 10:405.
2. Baeuerle, P. A., and T. Henkel. 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:141.
3. Holzer, P. 1994. Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol. Rev. 43:143.
4. Sicuteri, F., B. Fusco, S. Marabini, and M. Fanciullacci. 1988. Capsaicin as a potential medication for cluster headache. Med. Sci. Res. 16:1079.
5. Watson, C. P., R. J. Evans, and V. R. Watt. 1988. Post-herpetic neuralgia and topical capsaicin. Pain 33:333.
6. Marabini, S., G. Ciabatti, and G. Polli. 1988. Effect of topical nasal treatment with capsaicin in vasomotor rhinitis. Regul. Pept. 22:1.
7. Matucci-Cerinic, M., S. Marabini, S. Jantsch, M. Cagnini, and G. Partsch. 1990. Effects of capsaicin on the metabolism of rheumatoid arthritis synoviocytes in vitro. Ann. Rheum. Dis. 49:598.
8. Nilsson, G., and S. Ahlsledt. 1988. Altered lymphocyte proliferation of immunized rats after neurological manipulation with capsaicin. J. Immunopharmacol. 10:747.
9. Nilsson, G., K. Alving, and S. Ahlstedt. 1991. Effects of immune responses in rats after neuromanipulation with capsaicin. J. Immunopharmacol. 13:21.
10. Eglezos, A., P. V. Andrews, R. L. Boyd, and R. D. Helme. 1990. Effects of capsaicin treatment on immunoglobulin secretion in the rat: further evidence for involvement of tachykinin-containing afferent nerves. J. Neuroimmunol. 26:131.
11. Matucci-Cerinic, M., G. McCarthy, A. Lombardi, A. Pignone, and G. Partsch. 1995. Neurogenic influences in arthritis: potential modification by capsaicin. J. Rheumatol. 22:1447.
12. Chiba, T., S. Masuko, and H. Kawano. 1986. Correlation of mitochondrial swelling after capsaicin treatment and substance P and somatostatin immunoreactivity in small neurons of dorsal root ganglion in the rat. Neurosci. Lett. 64:311.
13. Morre, D. J., P.-J. Chueh, and D. M. Morre. 1995. Capsaicin inhibits preferentially the NADH oxidase and growth of transformed cells in culture. Proc. Natl. Acad. Sci. USA 92:1831.
14. Jancso, G., and M. Wollemann. 1977. The effect of capsaicin on the adenylate cyclase activities of the rat brain. Brain Res. 123:323.
15. Harvey, J. S., C. Davis, I. F. James, and G. M. Burgess. 1995. Activation of protein kinase C by the capsaicin analogue resiniferatoxin in sensory nerves. J. Neurochem. 65:1309.
16. Joe, B., and B. R. Lokesh. 1994. Role of capsaicin, curcumin and dietary n-3 fatty acids in lowering the generation of reactive oxygen species in rat peritoneal macrophages. Biochim. Biophys. Acta 1224:255.
17. Sun, I. L., E. E. Sun, F. L. Crane, D. J. Morre, A. Lindgren, and H. Low. 1992. Requirement for coenzyme Q in plasma membrane electron transport. Proc. Natl. Acad. Sci. USA 89:11126.
18. Szallasi, A. 1994. The vanilloid (capsaicin) receptor: receptor types and species differences. Gen. Pharmacol. 25:223.
19. Szallasi, A., N. A. Sharkey, and P. M. Blumberg. 1989. Structure/activity analysis of resiniferatoxin analogs. Phytother. Res. 3:253.
20. Szallasi, A., and P. M. Blumberg. 1990. Specific binding of resiniferatoxin, an ultrapotent capsaicin analog, by dorsal root ganglion membranes. Brain Res. 524:106.
21. Szallasi, A., and P. M. Blumberg. 1989. Resiniferatoxin, a phorbol-related diterpene, acts as an ultrapotent analog of capsaicin, the irritant constituent in red pepper. Neuroscience 30:515.
22. Acs, G., J. Lee, V. E. Marquez, S. Wang, G. W. A. Milne, L. Du, N. E. Lewin, and P. M. Blumberg. 1995. Resiniferatoxin-amide and analogues as ligands for protein kinase C and vanilloid receptors and determination of their biological activities as vanilloids. J. Neurochem. 65:301.
23. Chiao, P. J., S. Miyamoto, and I. M. Verma. 1994. Autoregulation of IκBα activity. Proc. Natl. Acad Sci. USA 91:28.
24. Schreiber, E., P. Matthias, M. M. Muller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with 'mini-extracts,' prepared from a small number of cells. Nucleic Acids Res. 17:6419.
25. Bradford, M. M. 1976. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248.
26. Nabel, G., and D. Baltimore. 1987. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 326:711.
27. Collart, M. A., P. Baeuerle, and P. Vassalli. 1990. Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four κB-like motifs and of constitutive and inducible forms of NF-κB. Mol. Cell. Biol. 10:1498.
28. Hassanain, H. H., W. Dai, and S. L. Gupta. 1993. Enhanced gel mobility shift assay for DNA-binding factors. Anal. Biochem. 213:162.
29. Singh, H., J. H. LeBowitz, A. S. Baldwin, Jr., and P. A. Sharp. 1988. Molecular cloning of an enhancer binding protein: isolation by screening of an expression library with a recognition site DNA. Cell 52:415.
30. Chaturvedi, M., R. LaPushin, and B. B. Aggarwal. 1994. Tumor necrosis factor and lymphotoxin: qualitative and quantitative differences in the mediation of early and late cellular responses. J. Biol. Chem. 269:14575.
31. Reddy, S. A. G., M. M. Chaturvedi, B. G. Darnay, H. Chan, M. Higuchi, and B. B. Aggarwal. 1994. Reconstitution of NF-κB activation induced by tumor necrosis factor requires membrane-associated components: comparison with pathway activated by ceramide. J. Biol. Chem. 269:25369.
32. Singh, S., and B. B. Aggarwal. 1995. Protein tyrosine phosphatase inhibitors block tumor necrosis factor-dependent activation of the nuclear transcription factor NF-κB. J. Biol. Chem. 270:10631.
33. Sambrook, J., E. E. Fritsch, and T. Maniatis, eds. 1989. Molecular Cloning: A Laboratory Mannual, 2nd Ed. Cold Spring Harbor Press, Cold Spring Harbor.
34. Finco, T. S., A. A. Beg, and A. S. Baldwin. 1994. Inducible phosphorylation of IκBα is not sufficient for its dissociation from NF-κB and is inhibited by protease inhibitors. Proc. Natl. Acad. Sci. USA 91:11884.
35. Mahon, T. M., and L. A. J. O'Neill. 1995. Studies into the effect of the tyrosine kinase inhibitor herbimycin A on NF-κB activation in T lymphocytes: evidence for covalent modification of the p50 subunit. J. Biol. Chem. 270:28557.
36. Thanos, D., and T. Maniatis. 1995. NF-κB: a lesson in family values. Cell 80: 529.
37. Kumar, S., A. B. Rabson, and C. Gelinas. 1992. The RxxRxRxxC motif conserved in all Rel/κB proteins is essential for the DNA-binding activity and redox regulation of the v-Rel oncoprotein. Mol. Cell. Biol. 12:3094.
38. Shirakawa, F., and S. B. Mizel. 1989. In vitro activation and nuclear translocation of NF-κB catalyzed by cyclic AMP-dependent protein kinase and protein kinase C. Mol. Cell. Biol. 9:2424.
39. Sun, S., S. B. Maggirwar, and E. Harhaj. 1995. Activation of NF-κB by phosphatase inhibitors involves the phosphorylation of IκBα at phosphatase SA-sensitive sites. J. Biol. Chem. 270:18347.
40. Suzuki, Y. J., M. Mizuno, and L. Packer. 1994. Signal transduction for nuclear factor-κB activation: proposed location of antioxidant-inhibitable step. J. Immunol. 153:5008.
41. Schmidt, K. N., E. B.-M. Traenckner, B. Meier, and P. A. Baeuerle. 1995. Induction of oxidative stress by okadaic acid is required for activation of transcription factor NF-κB. J. Biol. Chem. 270:27136.
42. Daniel, L. W., F. Civoli, M. A. Rogers, P. K. Smitherman, P. A. Raju, and M. Roederer. 1995. ET-18-OCH3 inhibits nuclear factor-κB activation by 12-0-tetradecanoylphorbol-13-acetate but not by tumor necrosis factor-α or interleukin-1α. Cancer Res. 55:4844.
43. Anisowicz, A., M. Messineo, S. W. Lee, and R. Sager. 1991. An NF-κB-like transcription factor mediates IL-1/TNF-α induction of gro in human fibroblasts. J. Immunol. 147:520.
44. Duyao, M. P., A. J. Buckler, and G. E. Sonenshein. 1990. Interaction of an NF-κB-like factor with a site upstream of the c-myc promoter. Proc. Natl. Acad. Sci. USA 87:4727.
45. La Rosa, F. A., J. W. Pierce, and G. E. Sonenshein. 1994. Differential regulation of the c-myc oncogene promoter by the NF-κB Rel family of transcription factors. Mol. Cell Biol. 14:1039.
46. Wu, H., and G. Lozano. 1994. NF-κB activation of p53: a potential mechanism for suppressing cell growth in response to stress. J. Biol. Chem. 269:20067.
47. Sarma, V., Z. Lin, L. Clark, B. M. Rust, M. Tewari, R. J. Noelle, and V. M. Dixit. 1995. Activation of the B-cell surface receptor CD40 induces A20, a novel zinc finger protein that inhibits apoptosis. J. Biol. Chem. 270:12343.
48. 1 transition in mouse fibroblasts. Mol. Cell Biol. 11:4943.
49. Lin, K.-I., S.-H. Lee, R. Narayanan, J. M. Baraban, J. M. Hardwick, and R. R. Ratan. 1995. Thiol agents and Bcl-2 identify an alphavirus-induced apoptotic pathway that requires activation of the transcription factor NF-κB. J. Cell Biol. 131:1149.